Trademark: 86938978
Word
ASCELTA
Status
Dead
Status Code
710
Status Date
Friday, July 7, 2023
Serial Number
86938978
Registration Number
5108168
Registration Date
Tuesday, December 27, 2016
Mark Type
4000
Filing Date
Monday, March 14, 2016
Published for Opposition
Tuesday, October 11, 2016
Cancellation Date
Friday, July 7, 2023

Trademark Owner History
GW Research Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical *preparations * and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut * syndrome * (LGS), tuberous sclerosis syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15q infantile spasms, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes
In the statement, Line 14, "preparations" is inserted after "pharmaceutical" In the statement, Line 15, "syndrome" is inserted after "Lennox-Gastaut".
The wording "ASCELTA" has no meaning in a foreign language.

Trademark Events
Jul 7, 2023
Cancelled Sec. 8 (6-Yr)
Dec 27, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2021
Assignment Of Ownership Not Updated Automatically
Nov 29, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 13, 2017
Amendment Under Section 7 ¿ Processed
Jun 12, 2017
Assigned To Paralegal
Mar 20, 2017
Teas Section 7 Request Received
Mar 20, 2017
Teas Change Of Correspondence Received
Dec 27, 2016
Registered-Principal Register
Oct 11, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 11, 2016
Published For Opposition
Sep 21, 2016
Notification Of Notice Of Publication E-Mailed
Sep 7, 2016
Law Office Publication Review Completed
Aug 30, 2016
Approved For Pub - Principal Register
Aug 30, 2016
Teas/Email Correspondence Entered
Aug 30, 2016
Correspondence Received In Law Office
Aug 24, 2016
Teas Response To Office Action Received
Aug 23, 2016
Teas/Email Correspondence Entered
Aug 23, 2016
Correspondence Received In Law Office
Aug 22, 2016
Assigned To Lie
Aug 15, 2016
Teas Response To Office Action Received
Jul 1, 2016
Notification Of Non-Final Action E-Mailed
Jul 1, 2016
Non-Final Action E-Mailed
Jul 1, 2016
Non-Final Action Written
Jun 24, 2016
Assigned To Examiner
Mar 17, 2016
New Application Office Supplied Data Entered
Mar 17, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24